The EPO published application EP4633534A1 for prosthetic valves and sensor systems, filed by Edwards Lifesciences Corporation. The invention relates to cardiac valve replacement technology with integrated sensor systems. The international patent classifications include A61F 2/24 (heart valves), A61B 5/0215 (cardiovascular measurement), and A61B 5/00 (diagnostic measuring). The application designates 44 European states including DE, FR, GB, IT, NL, ES, BE, SE, and others.

Patent publications do not create compliance obligations. Edwards Lifesciences and competitors should review the published claims to assess freedom-to-operate in the prosthetic valve space. The 18-month publication period allows parties to assess the application before substantive examination concludes. No action is required for most entities; this is informational for companies developing competing cardiac valve technologies.